Management & Regulatory

California Leads with New Healthcare Laws on Debt, Fertility, and Safety
Management & Regulatory California Leads with New Healthcare Laws on Debt, Fertility, and Safety

California, often recognized as a trendsetter in healthcare policy, continues to forge its path with several new laws aimed at improving various aspects of the healthcare system. As the country anticipates shifts in federal healthcare policy under President-elect Donald Trump, California's

Turkish Health Workers Protest Against Profit-Driven Regulations
Management & Regulatory Turkish Health Workers Protest Against Profit-Driven Regulations

Amid growing discontent with the Turkish healthcare system, a coalition of health workers has taken decisive action to protest against new regulations they argue prioritize profit over patient care. Beginning with a five-day work stoppage on January 6, these protests culminated in a general

Key Developments in Pharma: Gilead, Bristol Myers, Boundless Bio, Lonza
Management & Regulatory Key Developments in Pharma: Gilead, Bristol Myers, Boundless Bio, Lonza

The pharmaceutical and biotechnology sectors are witnessing a whirlwind of significant developments, from legal disputes over acquisition terms to pivotal personnel changes and strategic restructuring initiatives. These shifts are emblematic of an industry in constant evolution, driven by

Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?
Management & Regulatory Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?

In an effort to crack down on perceived inadequacies in the oversight of nonprofit hospitals’ charitable activities, the state of Montana has rolled out new rules aimed at closing long-standing gaps. This move stems from a legislative audit conducted more than four years ago, which critiqued the

EPA and FDA's Vital Role in Public Health: Recent Regulatory Actions
Management & Regulatory EPA and FDA's Vital Role in Public Health: Recent Regulatory Actions

Imagine a world where the air we breathe, the water we drink, and the food we eat are all unchecked, teeming with unseen hazards. For many, this is a nightmarish scenario, yet it highlights the importance of regulatory bodies such as the Environmental Protection Agency (EPA) and the Food and Drug

Is BioMarin's $60M Investment in Cork a Game-Changer for Biopharma?
Management & Regulatory Is BioMarin's $60M Investment in Cork a Game-Changer for Biopharma?

BioMarin Pharmaceutical Inc. has made headlines with its announcement of a significant €60 million investment geared towards the expansion of its state-of-the-art facility located in Shanbally, Co. Cork. This ambitious expansion plan encompasses the construction of a new four-story laboratory

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later